BMRN Stock Analysis: Buy, Sell, or Hold?
BMRN - BioMarin Pharmaceuticals Inc
$60.00
-0.03 (-0.04%)
▼
5d:
-0.46%
30d:
+1.7%
90d:
+10.98%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
1d
Smart Money Accumulation
None View Scanner →
Strength: 4.9/10
Get Alerted When BMRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BMRN shows positive signals but monitor for confirmation. Market pricing in 0.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BMRN shows positive signals but monitor for confirmation. Market pricing in 0.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$117.06
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$72.68
17.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BMRN is currently trading at $59.99, which is considered slightly high relative to its 30-day fair value range of $58.22 to $60.42. The stock's valuation (Forward PE: 9.4) is in line with its historical norms (9.4). Remarkably, the market is currently pricing in an annual earnings decline of 0.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BMRN is in a uptrend. Immediate support is located at $57.42, while resistance sits at $63.05.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $87.92 (+46.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BMRN is in a uptrend. Immediate support is located at $57.42, while resistance sits at $63.05.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $87.92 (+46.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$58.22 -
$60.42
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.2%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.5% below Wall St target ($87.92)
Trading Range Analysis
30-Day Trading Range
$58.22 -
$60.42
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$57.42
Resistance Level
$63.05
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.38
Wall Street Target
$87.92
(+46.5%)
Revenue Growth (YoY)
2.8%
Earnings Growth (YoY)
-43.1%
Profit Margin
8.3%
Valuation Discount vs History
-0.1% cheaper
PE vs Historical
9.4 vs 9.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.1%
(market-implied from PE analysis)
1-Year Target
$59.94
(0%)
2-Year Target
$59.88
(0%)
3-Year Target
$59.82
(0%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
$59.93
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 29.6%)
$288.50
(+381%)
Base:
(SPY PE: 9.4, Growth: 29.6%)
$130.57
(+118%)
Bear:
(PE: 8.0, Growth: 29.6%)
$110.99
(+85%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 43.18 | Current EPS (TTM): $1.39
Bull Case
$132.04
(+120%)
Analyst growth 100.0%, PE expands to 47.5
Base Case
$120.04
(+100%)
Market implied 100.0%, PE stable at 43.2
Bear Case
$40.81
(-32%)
Severe decline -20.0%, PE contracts to 36.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.4 to 9.4
Stabilization Target:
$60.11
(+0.2%)
PE Expansion Potential:
+0.2%
Share & Embed Analysis
Last updated: August 04, 2026 5:34 AM ET
Data refreshes hourly during market hours. Next update: 6:34 AM
Data refreshes hourly during market hours. Next update: 6:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Charles Greg Guyer
SELL
16486 shares
2026-03-11
Gregory R Friberg
SELL
6326 shares
2026-02-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
Advanced BMRN Option Strategies
Professional options setups generated by AI based on today's BMRN price and gamma walls.
